These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28483246)

  • 1. Comparison of first year of life acute otitis media admissions before and after the 13-valent pneumococcal conjugate vaccine.
    Marom T; Israel O; Gavriel H; Pitaro J; Baker AA; Eviatar E
    Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():251-256. PubMed ID: 28483246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pneumococcal conjugate vaccines on incidence and microbiology associated with complicated acute otitis media.
    Laursen BB; Danstrup CS; Hoffmann S; Nørskov-Lauritsen N; Christensen ALB; Ovesen T
    Int J Pediatr Otorhinolaryngol; 2017 Oct; 101():249-253. PubMed ID: 28964304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Acute Otitis Media in the Era of Pneumococcal Vaccination.
    Tawfik KO; Ishman SL; Altaye M; Meinzen-Derr J; Choo DI
    Otolaryngol Head Neck Surg; 2017 May; 156(5):938-945. PubMed ID: 28349737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epidemiological and Financial Effects of Pneumococcal Vaccination on Otitis Media Related Admissions in the United States.
    Grobman A; Reddy P; Wolfovitz A; Sylvester M; Angeli SI
    Ann Otol Rhinol Laryngol; 2021 Jul; 130(7):760-768. PubMed ID: 33183064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of pneumococcal conjugate vaccines on acute otitis media in Japan.
    Sasaki A; Kunimoto M; Takeno S; Sumiya T; Ishino T; Sugino H; Hirakawa K
    Auris Nasus Larynx; 2018 Aug; 45(4):718-721. PubMed ID: 29102419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland.
    Allemann A; Frey PM; Brugger SD; Hilty M
    Vaccine; 2017 Apr; 35(15):1946-1953. PubMed ID: 28279564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England.
    Mohanty S; Podmore B; Cuñado Moral A; Weiss T; Matthews I; Sarpong E; Méndez I; Qizilbash N
    BMC Public Health; 2023 Jan; 23(1):201. PubMed ID: 36717794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
    Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
    Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal conjugate vaccines for preventing otitis media.
    Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2014 Apr; (4):CD001480. PubMed ID: 24696098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pneumococcal conjugated vaccines on occurrence of recurrent acute otitis media among infants diagnosed with acute otitis media at an age younger than 2 months.
    Ziv O; Adelson D; Sadeh R; Kordeluk S; El-Saied S; Leibovitz E; Kraus M; Kaplan D
    Eur J Pediatr; 2023 Jun; 182(6):2873-2879. PubMed ID: 37052673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Otitis Media Incidence After Conjugate Pneumococcal Vaccination: A National Observational Study.
    Gisselsson-Solen M
    Pediatr Infect Dis J; 2017 Nov; 36(11):1027-1031. PubMed ID: 28657970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of acute otitis media in children in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998-2018.
    Hu T; Done N; Petigara T; Mohanty S; Song Y; Liu Q; Lemus-Wirtz E; Signorovitch J; Sarpong E; Weiss T
    BMC Infect Dis; 2022 Mar; 22(1):294. PubMed ID: 35346092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US.
    Shea KM; Weycker D; Stevenson AE; Strutton DR; Pelton SI
    Vaccine; 2011 Oct; 29(45):8042-8. PubMed ID: 21871518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
    Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare Costs for Pneumococcal Disease in the Era of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine: A Population-Based Study.
    Vadlamudi NK; Sadatsafavi M; Patrick DM; Rose C; Hoang L; Marra F
    Value Health; 2022 Sep; 25(9):1510-1519. PubMed ID: 35466049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Streptococcus pneumoniae causing acute otitis media among children in Southern Catalonia throughout 2007-2013: Incidence, serotype distribution and vaccine's effectiveness.
    Ochoa-Gondar O; Figuerola-Massana E; Vila-Corcoles A; Aguirre CA; de Diego C; Satue E; Gomez F; Raga X;
    Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2104-8. PubMed ID: 26453272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era.
    Kaur R; Morris M; Pichichero ME
    Pediatrics; 2017 Sep; 140(3):. PubMed ID: 28784702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of acute otitis media, recurrent otitis media and tympanostomy tube insertion in children after its implementation into the national immunization program in Turkey.
    Soysal A; Gönüllü E; Yıldız I; Aydemir G; Tunç T; Fırat Y; Erdamar B; Karaböcüoğlu M
    Hum Vaccin Immunother; 2020; 16(2):445-451. PubMed ID: 31424317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation.
    Cohen R; Varon E; Doit C; Schlemmer C; Romain O; Thollot F; Béchet S; Bonacorsi S; Levy C
    Vaccine; 2015 Sep; 33(39):5118-26. PubMed ID: 26271823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.
    Suarez V; Michel F; Toscano CM; Bierrenbach AL; Gonzales M; Alencar AP; Ruiz Matus C; Andrus JK; de Oliveira LH
    Vaccine; 2016 Sep; 34(39):4738-4743. PubMed ID: 27521230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.